Investor

Nexus Medical Partners

Last cheque observed May 2012. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

Series BSeries ASeries CLife Science

Cheques on record
0%of best year0cheques in 12 months, 16 on record
Since the last cheque5269days00hrs00min00sec
Median round$6.5MRounds led0 of 16Sole investor2 roundsExits2 from the portfolioMostly inUnited States, 100%
Pitch Nexus Medical Partners

Nexus Medical Partners highlights

  1. 01

    16 rounds on record

  2. 02

    Mostly Series B and Series A: 53% of its rounds

  3. 03

    Sole investor in 2 rounds, median $2.0M

  4. 04

    2 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Sectors
Life Science
Cold pitches
Not stated

The record

Every round we can evidence, newest first16 appearances

  1. 2012

    3 rounds

  2. May
    KIYATECSeries A · US · finsmes.comUndisclosedWith 1 other
  3. May
    Zipit WirelessUS$2.6MWith 6 others
  4. Mar
    MyoScienceSeries D · US · finsmes.com$33MWith 4 others
  5. 2011

    1 round

  6. Nov
    Zipit WirelessDebt · US · sec.gov$1.8MWith 6 others
  7. 2010

    3 rounds

  8. Aug
    Sabal MedicalDebt · US$500KWith 2 others
  9. Jul
    Zipit WirelessSeries C · US$4.0MWith 6 others
  10. Feb
    Zipit WirelessSeries C · US$3.6MWith 5 others
  11. 2008

    4 rounds

  12. Jul
    Sabal MedicalSeries B · USUndisclosedSole investor
  13. Jul
    MyoScienceSeries B · US$10MWith 3 others
  14. May
    Selah TechnologiesSeries A · US$1.6MWith 1 other
  15. Mar
    EyeGate PharmaceuticalsSeries C · US · eyegatepharma.com$15MWith 3 others
  16. 2007

    3 rounds

  17. Aug
    Presidio PharmaceuticalsSeries B · US · presidiopharma.com$26MWith 4 others
  18. Jun
    Cequent PharmaceuticalsSeries A · US · cequentpharma.com$9.0MWith 4 others
  19. Jan
    EyeGate PharmaceuticalsSeries B · US$2.0MSole investor
  20. 2006

    2 rounds

  21. Nov
    Magellan DiagnosticsGrowth · US$50MWith 6 others
  22. Nov
    NeurotechSeries B · US · neurotechusa.com$35MWith 11 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

Sabal MedicalBought by Swisslog Group.UndisclosedJan 2011
Selah TechnologiesBought by Lab21UndisclosedDec 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Nexus Medical Partners. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Nexus Medical Partners

What does Nexus Medical Partners invest in?

Nexus Medical Partners invests most often at Series B and Series A (53% of the rounds on record), in sectors such as Life Science.

How active is Nexus Medical Partners?

16 investments on record, 0 of them in the last 12 months. The most recent was in May 2012.

How big are Nexus Medical Partners's cheques?

The median round it joins is $6.5M.

Does Nexus Medical Partners lead rounds?

Rarely, if at all: none of its 16 investments on record names it as the lead.

Where does Nexus Medical Partners invest?

Most of the companies it backs are in the United States (100%).

Is Nexus Medical Partners investing now?

No investments in the last 12 months; the latest was in May 2012.

Who does Nexus Medical Partners invest alongside?

Most often Upstate Carolina Angel Network (7 rounds together), South Carolina Research Authority (5 rounds together) and Meritus Ventures (4 rounds together).

What kind of investor is Nexus Medical Partners?

Nexus Medical Partners is a VC firm.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it